Business, energy, technology, markets and global industry news from Business News Today

Galderma Group AG

PharmaDeviceNews Galderma Group AG
Pharma & Biotech

Galderma wins China approval for Relfydess, but can its six-month wrinkle treatment challenge established Botox rivals?

Galderma wins China approval for Relfydess after positive Phase 3 frown line results. Competition and its pending US review remain crucial.

Read More
Galderma’s Restylane Shaype has secured European Union approval for temporary chin augmentation, expanding the company’s high-firmness hyaluronic acid filler portfolio as competition intensifies in facial shaping and injectable aesthetics. Representative image.
Medical Devices & Diagnostics

Restylane Shaype has cleared Europe, but can Galderma turn its “bone-mimicking” filler into a new chin-shaping standard?

Galderma’s Restylane Shaype gains EU MDR approval for chin augmentation, bringing its high-firmness NASHA HD filler into Europe.

Read More
Galderma expands Alastin professional skincare across Japan and key Asia Pacific medical aesthetics markets as demand for procedure-linked skincare grows. Representative image.
Pharma & Biotech

Galderma is taking Alastin deeper into Asia, but this launch is about more than skincare

Galderma expands Alastin across Japan and Asia Pacific, linking premium skincare with rising demand for aesthetic procedures.

Read More
Pharma & Biotech

Galderma’s relabotulinumtoxinA FDA setback shifts attention to manufacturing readiness

Discover why FDA manufacturing concerns have delayed Galderma’s relabotulinumtoxinA approval and what the company must resolve next.

Read More